Among the infections caused by Gram-negative bacteria, non-fermenting Gram-negative organisms such as Pseudomonas aeruginosa and Acinetobacter baumannii are troublesome. They cause wide range of infections such as bacteremia, pneumonia, skin and soft tissue infections and urinary tract infections. [1] Infections caused by MDR, XDR and PDR P. aeruginosa and A. baumannii results in high morbidity and mortality rates, especially in immunocompromised individuals.
P. aeruginosa has the ability to resist wide range of anti-pseudomonal agents. It develops resistance through intrinsic and extrinsic resistance mechanisms. [2] Intrinsic includes over-expression of efflux pumps (mexAB, mexCD, mexEF and mexXY), chromosomal hyper ampC producers and loss of porins (OprD); extrinsic includes acquisition of resistance genes such as extended spectrum beta-lactamases (ESBLs; bla SHV , bla TEM , bla VEB , bla PER and bla OXA types) and carbapenemases (bla GES , bla KPC , bla IMP , bla SPM , bla VIM and bla NDM ). [3, 4] Of these mechanisms, plasmid-mediated resistance genes are mostly studied due to its rapid dissemination. Conversely, chromosomal resistance has not been paid much attention. [5] Mortality rate seen in P. aeruginosa pneumonia is up to 70%. [6] A. baumannii is resistant to almost all the available drugs and increased antimicrobial resistance has been implicated in nosocomial infections and hospital outbreaks. The mortality rates seen with A. baumannii caused pneumonia and blood stream infections were between 40%-70% and 28%-43%, respectively. [7] Unlike P. aeruginosa, antimicrobial resistance in A. baumannii is predominantly through acquired resistance mechanisms such as production of ESBLs and class A carbapenemases (bla PER , bla TEM , bla SHV , bla GES and bla KPC ), class B metallo β-lactamases (MBLs; bla NDM , bla VIM and bla IMP ), class C β-lactamases (acinetobacter derived cephalosporinases) and the most common class D β-lactamases (bla OXA-23 like, bla OXA-24 like and bla OXA-58 like). Non-enzymatic mechanisms such as membrane impermeability by either loss of or decrease in expression of outer membrane proteins (CarO) or an increased expression of efflux pumps (AdeABC) also contributes to antimicrobial resistance in A. baumannii. [8] [9] [10] Studies have reported that co-occurrence of class D β-lactamases and overexpression of efflux system contribute to increased resistance in A. baumannii. [11] As there is a great need for surveillance studies in India, the Indian Council of Medical Research (ICMR) undertook this surveillance study across four different centres from India. This includes All India Institute of Medical Sciences (AIIMS), Delhi; Christian Medical College (CMC), Vellore; Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry (JIPMER) and Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. The main purpose of this study was to (i) establish "Antimicrobial Resistance Surveillance Network" in India; (ii) to monitor the antimicrobial susceptibility profile of clinical isolates; and (iii) to look for the prevalence of various enzymes conferring resistance in clinical isolates. Herein we report the molecular resistance mechanisms of clinical isolates of P. aeruginosa and A. baumannii collected across India during 2014-2015.
Materials and Methods

Bacterial strains
A total of 552 clinically significant, non-duplicate isolates of P. aeruginosa (n = 240) and A. baumannii (n = 312) were received from AIIMS (New Delhi), CMC (Vellore), JIPMER (Puducherry) and PGIMER (Chandigarh) during January 2014-December 2015. Among 240 P. aeruginosa isolates, 125, 55, 36, 13, 7 and 3 were from respiratory secretions (broncho-alveolar lavage and endotracheal secretions), blood, pus, intra-abdominal secretions, urine and cerebrospinal fluid specimens, respectively. Similarly, among 312 A. baumannii isolates, 165, 77, 37, 22, 6 and 5 were from respiratory secretions, blood, pus, intra-abdominal secretions, CSF and urine specimens, respectively. The organisms were identified up to the species level using standard biochemical tests. [12] Further confirmation of A. baumannii was done using bla OXA-51Like polymerase chain reaction (PCR) which is intrinsic to this species. [13] Antimicrobial susceptibility testing Antimicrobial susceptibility testing for different classes of antimicrobials such as cephalosporins (cefotaxime, ceftazidime); β-lactam/β-lactamase inhibitors (piperacillin/ tazobactam); carbapenems (imipenem, meropenem); fluoroquinolones (ciprofloxacin, levofloxacin) and PB300 units; tigecycline (only for A. baumannii) was performed for all the isolates by Kirby Bauer disk diffusion method and interpreted according to Clinical Laboratory Standards Institute guidelines 2014 and 2015. [14, 15] Isolates showing resistance to at least one agent in each of these three or four groups (cephalosporins, carbapenems, fluoroquinolones and/or aminoglycosides) were considered as MDR and included in the study for further characterisation.
Carba NP (for P. aeruginosa): A subset of 111 isolates of carbapenem-resistant P. aeruginosa was randomly chosen and subjected to Carba NP test as described previously. [16] The isolates were grown on Mueller-Hinton agar plates for 24 h and isolated colonies were subjected for Carba NP testing.
CarbAcineto NP test (for A. baumannii): A subset of 105 isolates of carbapenem resistant A. baumannii was randomly chosen, and a modified protocol of Carba NP known as CarbAcineto NP test was used. [17] Class D oxacillinases are more prevalent in Acinetobacter spp., a reformed protocol using 5 M NaCl was used instead of BPER-II lysis buffer, to avoid any buffer effect, as bla OXA enzymes possess weak carbapenemase activity.
For both Carba NP and CarbAcineto NP tests, Klebsiella pneumoniae ATCC BAA 1705 and Klebsiella pneumoniae ATCC BAA 1706 were used as positive and negative controls, respectively, in all the assays. Change of the colour of phenol red indicator from red to yellow was taken as positive for carbapenemase production. The absence of colour change from red to yellow was taken as negative result. The observation of colour change was taken by two independent readers.
Imipenem + cloxacillin test (only for P. aeruginosa):
Randomly chosen 53 isolates of P. aeruginosa were tested for imipenem and cloxacillin synergism testing. The most common non-carbapenemase mediated resistance mechanism in P. aeruginosa is porin loss with hyperproduction of chromosomal ampC enzymes. Combination disc test was done for imipenem and cloxacillin as described previously, to demonstrate the ampC production. [18] Cloxacillin of 4000 µg/ml was used alone and in combination with imipenem (10 µg/ml). More than 5 mm difference in the zone diameter between imipenem alone and in combination of imipenem with cloxacillin was taken as positive result for chromosomal hyper ampC producers in P. aeruginosa.
Multiplex polymerase chain reaction for detection of extended spectrum beta-lactamases and carbapenemase genes
All the test isolates were grown on blood agar overnight, and genomic DNA was extracted by boiling lysis method. [19] Conventional multiplex PCR was done for the detection of ESBL genes such as bla TEM , bla SHV , bla PER , and bla VEB , and carbapenemase genes such as bla GES , bla SPM , bla IMP , bla VIM , bla NDM , bla KPC , bla OXA-48 like as described previously; [20] and bla SIMLike (Only for A. baumannii). [21] In addition, the presence of class D carbapenemase genes such as bla OXA-23 like, bla OXA-24 like and bla OXA-58 like were screened for A. baumannii isolates by multiplex PCR. [22] The amplicons were visualised in 2% agarose gel with staining by ethidium bromide. Known positive controls for appropriate genes were used for every run (courtesy: IHMA, Inc., USA).
Results
Pseudomonas aeruginosa
Phenotypic test results -CarbaNP A total of 111 isolates were screened for carbapenemase production by Carba NP test. 37% (n = 41) of isolates showed Carba NP test positive and 63% (n = 70) of isolates showed Carba NP test negative. Among the Carba NP positives (n = 41), 81% were found to be due to the carbapenemase production such as bla NDM , bla VIM and bla VIM + NDM , while 19% were negative in PCR for the carbapenemase genes tested. Similarly, for Carba NP negatives (n = 70), carbapenemase genes were found in 17% (n = 12) of isolates producing bla GES , bla NDM , bla VIM and bla VIM+NDM ; while 83% (n = 58) were negatives in PCR for the carbapenemase genes tested.
AmpC hyper-producers
AmpC hyperproduction analysis was carried out for a subset of randomly chosen isolates (n = 53). Among the 53 isolates tested, 36% (n = 19) were carbapenemase producers; and 64% (n = 34) were non-carbapenemase producers. Notably, 26% (n = 5/19) of the carbapenemase producers showed positive for ampC hyperproduction (this includes 45% (n = 5/11) of bla VIM producers). 74% were negative, which includes bla VIM (n = 6) and NDM (n = 8). Among the non-carbapenemase producers, 82% (n = 28/34) were found to be positive for ampC hyper production tests, while 18% (n = 6/34) were negative.
Genotypic results of β lactamases
Extended spectrum beta lactamases Among the 240 P. aeruginosa screened, 29% (n = 69) of the isolates were positive for the ESBL genes tested. This includes, 23% (n = 56) of bla VEB , 5% (n = 12) of bla TEM and 0.4% (n = 1) of bla SHV . Of the ESBL genes, bla VEB was found to be the most common followed by bla TEM and bla SHV . Co-producers of bla SHV and bla TEM were also found. However, among the ESBL positives, geographical distribution was found to be almost similar for bla TEM . Notably, all the isolates (n = 21) from PGIMER were positive for bla TEM gene. bla SHV was identified only in CMC isoaltes, while other ESBLs have been identified across all the four study centres. Overall, ESBL rates were ranged from 15% to 100% across the study sites, with 23%, 24%, 15% and 100% in AIIMS, CMC, JIPMER and PGIMER, respectively. This varying ESBL rates could be due to the unequal number of isolates tested from each of the study centres.
Carbapenemases
Among the 240 P. aeruginosa screened, 8% (n = 18) were of class A (bla GES ) carbapenemase and 53% (n = 127) class B carbapenemases (MBLs -bla VIM , bla NDM and bla IMP ). Class D carbapenemases (bla OXA-48 like) was not detected in any of the isolates tested. Geographical distribution of carbapenemase classes varied among the study centres. Class A carbapenemases were not detected in AIIMS, while 6%, 12% and 10% were detected in CMC, JIPMER and PGIMER, respectively. However, among the class B carbapenemases (MBLs), bla IMP , bla VIM , bla NDM was identified except bla SPM . Within that, bla VIM were detected in 24%-57%, bla NDM were 8%-19% and bla IMP were 4%-5%, respectively. bla NDM was not observed among PGIMER isolates. Overall, the carbapenemase rates were ranged from 6% to 12% and 38%-75% for class A and class B Indian Journal of Medical Microbiology vol. 34, No. 4 carbapenemases, respectively. Interestingly, from JIPMER study isolates, 75% were MBL producers, this is alarming. While 54%, 38% and 57% MBLs were detected in AIIMS, CMC and PGIMER isolates, respectively. These differences in the rates of carbapenemases could be due to the unequal number of isolates tested from each centres. Molecular profiles of β-lactamases in P. aeruginosa are summarised in Table 1 .
Acinetobacter baumannii
Phenotypic test results-CarbAcineto NP CarbAcineto NP test was done for a total of 105 isolates of A. baumannii. Of which, 88% (n = 92) of the isolates were positive and 12% (n = 13) were negative. Among the 92 positive isolates, 91 isolates were positive for class D bla OXA-23 like gene and 13 isolates were positive for one of the following class B carbapenemases, bla NDM and/or bla VIM gene. Of the 13 CarbAcineto NP negatives, bla OXA-23 like gene was present in all the isolates, whereas one isolate was positive for either bla NDM or bla VIM gene.
Genotypic results of β lactamases
Extended spectrum beta lactamases Among the 312 A. baumannii screened, 71% (n = 223) of the isolates were positive for the ESBL genes tested. This includes, 54% (n = 169) of bla PER , 16% (n = 50) of bla TEM and 1% (n = 4) of bla SHV . bla PER was found to be the most common ESBL gene followed by bla TEM and bla SHV . All the study isolates were negative for bla VEB. In addition, co-producers of bla PER , bla TEM , and bla NDM , were found. Geographical distribution of both bla PER and bla TEM was found to be almost similar across the four study centres, whereas bla SHV was identified in CMC and PGIMER isolates.
Carbapenemases
Class A carbapenemases (bla GES and bla KPC ) was not detected in any of the study isolates tested. Twenty-five percent (n = 78) of the isolates were positive for class B carbapenemases, of which 22% were bla NDM (n = 69) followed by 3% of bla VIM (n = 9). None of the isolates harboured bla IMP , bla SPM and bla SIM genes. Intrinsic class D carbapenemase, bla OXA-51 like was found in all the study isolates whereas acquired class D carbapenemases such as bla OXA-23 like and bla OXA-58 like was found to be 98% (n = 306) and 2% (n = 6), respectively. bla OXA-48 like and bla OXA-24 like was not detected in any of the isolates tested. Geographical distribution was found to be almost similar for both bla OXA-51 like and bla OXA-23 like across all the four study centres, whereas bla OXA-58 like was found in AIIMS, CMC and JIPMER isolates. Molecular profiles of β lactamases in A. baumannii are summarised in Table 2 .
Discussion
Antimicrobial resistance surveillance plays an important role in tracking resistance to various antimicrobial agents. Active surveillance has been carried out by various studies including ANSORP, SMART, ABCS, SCOPE, SENTRY, MYSTIC, TEST, CHINET and EARS. Of all these studies, India being a participating centre is very less [ Table 3 ]. Tables 4 and 5 summarise the cumulative report of molecular resistance mechanisms carried out in various Indian hospitals. To address this gap, ICMR has initiated the network to document and monitor the antimicrobial resistance across various regions in India.
MDR rates in P. aeruginosa ranged from 20% to 30% and in A. baumannii ranged from 40% to 50% in India (unpublished data). In P. aeruginosa, molecular analysis of ESBL revealed the presence of bla VEB , bla TEM and bla SHV . Among the ESBLs, bla VEB was the most common followed by bla TEM and bla SHV . Notably, regional distribution of ESBLs varied across regions. In particular, PGIMER isolates showed 100% (n = 21/21) bla VEB positivity, while in other centres it ranged from 12% to 19%. Molecular profile of ESBL genes by other Indian studies shows similar profile for bla TEM and bla SHV genes. [26, 29] However, bla PER gene was not seen in this study isolates of P. aeruginosa, which is in contrast to 17% reported. [31] Carbapenem resistance in P. aeruginosa due to carbapenemase was found to be 44%. Of the carbapenemases, bla VIM is the most common MBL identified. This observation is in concurrence with the previous reports, wherein, bla VIM mediated resistance is common in P. aeruginosa. [25, [27] [28] [29] 32, 34, 41, 42] Although bla NDM is widespread across India, the isolation rate of bla NDM in P. aeruginosa is less. This study detected about 8%-19%, while PGIMER isolates did not harbour bla NDM . These regional variation needs to be further confirmed with testing of more number of isolates. However, this finding is similar with the other Indian studies, wherein the rates of bla NDM ranged from 5% to 24%. [29, 33, 34] In additional, ampC mediated resistance to carbapenems are reported at much higher rates than carbapenemases. In this study, subset analysis of non-carbapenemase producers showed that 82% of carbapenem resistance was contributed by porin loss and/or chromosomal ampC hyper production, which is also confirmed by Upadhyay et al., of about 43%. [30] In A. baumannii, bla PER (54%) was the most common ESBL followed by bla TEM and bla SHV . The incidence of bla PER was found to be similar across all the study centres. Carbapenem resistance in A. baumannii is most predominantly occurs due to chromosomal/ plasmid-mediated class D oxacillinases (bla OXA-51 like and bla OXA-23 like) followed by class B MBL (bla NDM and bla VIM ), respectively. In this study, carbapenem resistance due to bla OXA-23 like was found to be 98%, which shows concordance with other studies [22, 36, 39, 40, 43] whereas bla NDM and bla VIM were about 22% and 3%, respectively. [28, 36] 
Conclusion
From this study, it was clear that ESBLs and carbapenemases detected from the clinical isolates varies widely for P. aeruginosa and A. baumannii. In P. aeruginosa, plasmid-mediated mechanisms are much lesser than the chromosomal mediated mechanisms. In A. baumannii, class D oxacillinases are more common, than the other mechanisms. Continuous surveillance will help to monitor and control the spread of antimicrobial resistance. Also, the cumulative national data will help policy makers to advice on appropriate empirical treatment guideline. Further, this report highlights the β-lactamase profile in P. aeruginosa and A. baumannii clinical isolates seen in India. Based on this, the suitable β-lactamase inhibitor can be recommended in combination with β-lactams. However, these inhibitors based combinations needs to be evaluated and monitored. This includes avibactam, which is clinically active against Class A and C β-lactamases seen in P. aeruginosa and aztreonam with avibactam which is active against MBL producers. Whereas for class D OXA carbapenemases (bla OXA-23/24/51/58 like), it needs to be explored. [23] MYSTIC [24] SENTRY [25] [26] 2012-2013, Uttar Pradesh 35 bla CTX-M : 17.1 AmpC: 37 Ramakrishnan et al., 2014 [27] 2009-2010, Puducherry 75 (MDR) bla VIM-2 : 13.33 bla IMP-1 : 10.33 Amudhan et al., 2012 [28] 2010-2010, Chennai 61 bla VIM and bla IMP : 59 Chaudhary and Payasi, 2013 [29] [30] 2008-2009, Uttar Pradesh AmpC Chromosomal ampC: 43 Saxena et al., 2015 [31] 2012, Uttar Pradesh ESBL -24 bla CTX-M1 : 8 bla CTX-M2 : 21 bla PER : 17 Manoharan et al., 2010 [32] 2005-2007, SARI Study, India
MBLs -17 bla VIM : 88 Shanthi et al., 2014 [33] 2010 Carbapenem resistant -61 bla NDM : 5 bla NDM +bla VIM : 1 Khajuria et al., 2013 [34] 2011-2012 Carbapenem resistant -40 bla VIM : 40 bla NDM : 10
